Trial NCT01009203

View at ClinicalTrials.gov 
Org. Study IDs: INST OSI4641s
Secondary IDs: NCI-2011-02948 OSI4641s

Last trial update was posted on 2015-08-10

MeSH Interventions

Erlotinib Hydrochloride MTOR Inhibitors Sirolimus Temsirolimus

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell

Other Conditions

Squamous Cell Carcinoma

Stopping Reasons

High patient withdrawal rate

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID